Sugi Predict

Sugi Predict / Compounds / SCHEMBL20067201

SCHEMBL20067201

SCHEMBL20067201

CCCCCc1ccc(-c2ccc(-c3cc(O)c(CCO)cc3O)c(F)c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RARB P10826 10/20 0.52
▸ RARA P10276 2/20 0.52
▸ RARG P13631 1/20 0.52
▸ ALDH1A1 P00352 2/20 0.40
▸ ESR1 P03372 2/20 0.40
▸ ADRA2A P08913 2/20 0.40
▸ ADORA3 P0DMS8 2/20 0.40
▸ TACR2 P21452 2/20 0.40
▸ SLC6A2 P23975 2/20 0.40
▸ SLC6A4 P31645 2/20 0.40
▸ SLC6A3 Q01959 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ SHBG P04278 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ HSPD1 P10809 1/20 0.40
▸ ADRB3 P13945 1/20 0.40
▸ HTR2C P28335 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15725339 0.86 RARB (0.64) RARBRARARARGALDH1A1ESR1
SCHEMBL14175167 0.83 RARB (0.66) RARBRARARARGALDH1A1ESR1
SCHEMBL23641055 0.82 RARB (0.55) RARBRARARARGALDH1A1ESR1
SCHEMBL9230819 0.82 RARB (0.62) RARBRARARARGALDH1A1ESR1
SCHEMBL21322007 0.82 RARB (0.62) RARBRARARARGALDH1A1ESR1
SCHEMBL31746995 0.81 RARB (0.47) RARBRARARARGALDH1A1ESR1
SCHEMBL17070355 0.81 RARB (0.47) RARBRARARARGALDH1A1ESR1
SCHEMBL14175164 0.81 RARB (0.64) RARBRARARARGALDH1A1ESR1
SCHEMBL9563730 0.81 RARB (0.68) RARBRARARARGALDH1A1ESR1
SCHEMBL13310852 0.81 RARB (0.68) RARBRARARARGALDH1A1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10184080-B2 Liquid crystal materials, methods of fabricating liquid crystal display panels and liquid crystal display panels SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) 2019-01-22 — — US disclosed
US-20180105750-A1 LIQUID CRYSTAL MATERIALS, METHODS OF FABRICATING LIQUID CRYSTAL DISPLAY PANELS AND LIQUID CRYSTAL DISPLAY PANELS SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) 2018-04-19 — — US disclosed
US-20180105750-A1 LIQUID CRYSTAL MATERIALS, METHODS OF FABRICATING LIQUID CRYSTAL DISPLAY PANELS AND LIQUID CRYSTAL DISPLAY PANELS SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) 2018-04-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10184080-B2 Liquid crystal materials, methods of fabricating liquid crystal display panels and liquid crystal display panels VCL, PI4K2A, PLK4 RARB 3287/4885RARA 1870/4885RARG 2615/4885
US-20180105750-A1 LIQUID CRYSTAL MATERIALS, METHODS OF FABRICATING LIQUID CRYSTAL DISPLAY PANELS AND LIQUID CRYSTAL DISPLAY PANELS VCL, PI4K2A, PLK4 RARB 3287/4885RARA 1870/4885RARG 2615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.